The gene that encodes HER2 is amplified in 15–20% of all breast cancers and defines a uniquely aggressive natural history with high grade histologies, greater likelihood to metastasize to visceral sites, and shortened survivals [4,5]. The gene discussed is ERBB2; the disease is breast cancer.